Presence of activated T-cells with a T8+ M1+ Leu 7+ surface phenotype in invaded lymph nodes from patients with solid tumors.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Journal of the National Cancer Institute

• Publication date

  1986-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNCI/77.3.637PMID 3091897
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Production of B cell growth factor by a Leu-7+, OKM1+ non-T cell with the features of large granular lymphocytes (LGL).

  1985cited by this paper
• Isolation and functional analysis of human B cell populations. I. Characterization of the B1+B2+ and B1+B2- subsets.

  1985cited by this paper
• Immunohistologic localization and immune phenotypes of lymphocytes expressing Tac antigen in human lymphoid tissues.

  1984cited by this paper
• Morphologic and phenotypic features of the subpopulation of Leu-2+ cells that suppresses B cell differentiation.

  1984cited by this paper
• Human natural killer cells: biologic and pathologic aspects.

  1984cited by this paper
• Distribution and heterogeneity of cells detected by HNK-1 monoclonal antibody in blood and tissues in normal, reactive and neoplastic conditions.

  1984cited by this paper
• Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors.

  1983cited by this paper
• PHA-induced human T cell colony formation: enhancing effect of large granular lymphocytes.

  1983cited by this paper
• Leu 7+ (HNK-1+) cells. I. Selective compartmentalization of Leu 7+ cells with different immunophenotypes in lymphatic tissues and blood.

  1983cited by this paper
• Relationship between Human T Cell Functional Heterogeneity and Human T Cell Surface Molecules

  1983cited by this paper
• Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies.

  1983cited by this paper
• B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.

  1983cited by this paper
• Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses.

  1983cited by this paper
• Tissue distribution of human NK cells studied with anti-Leu-7 monoclonal antibody.

  1983cited by this paper
• NKP-15: a monoclonal antibody reactive against purified human natural killer cells and granulocytes.

  1983cited by this paper
• Immunoregulatory T cell circuits in man. Alloantigen-primed inducer T cells activate alloantigen-specific suppressor T cells in the absence of the initial antigenic stimulus

  1983cited by this paper
• Surface markers on leukemia and lymphoma cells: recent advances.

  1982cited by this paper
• A rapid rosette technique for quantitation and separation of mononuclear cell subsets using monoclonal antibodies.

  1982cited by this paper
• A rapid technique for isolation of viable tumor cells from solid tumors: use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses.

  1982cited by this paper
• A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).

  1981cited by this paper
• Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies.

  1981cited by this paper
• Analysis of HLA-DR polymorphism by two-dimensional peptide mapping.

  1981cited by this paper
• A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

  1981cited by this paper
• Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man

  1981cited by this paper
• Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies.

  1981cited by this paper
• A monoclonal antibody reactive with human peripheral blood monocytes.

  1980cited by this paper
• The differentiation and function of human T lymphocytes.

  1980cited by this paper
• Characterization of a human B lymphocyte-specific antigen.

  1980cited by this paper
• Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells

  1979cited by this paper
• COMPARATIVE STUDY OF MEMBRANE AND INTRACYTOPLASMIC IMMUNOGLOBULIN CLASSES IN HUMAN LYMPHOID CELLS *

  1975cited by this paper

• Fight the Cancer, Hit the CAF!

  2022cites this paper
• Immunologic parameters as significant prognostic factors in lung cancer.

  2002cites this paper
• Melatonin in Patients with Cancer of Extra-Reproductive Location

  2001cites this paper
• Cellular immunologic parameters related to age, gender, and stage in lung cancer patients.

  2000cites this paper
• Increased thromboxane A2 production at primary tumor site in metastasizing squamous cell carcinoma of the larynx.

  1993cites this paper
• The changing importance of prognostic factors in bladder cancer during a long-term follow-up.

  1993cites this paper
• Tumor-infiltrating lymphocytes

  1992cites this paper
• Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy.

  1992cites this paper
• Tumor-infiltrating lymphocytes as antitumor effector cells

  1992cites this paper
• Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer.

  1992cites this paper
• Intravesical Bacillus Calmette-Guérin treatment for superficial bladder cancer: results after 15 years of experience.

  1991cites this paper
• Functional and phenotypic analysis of lymphocytes in head and neck cancer.

  1991cites this paper
• In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.

  1990cites this paper
• The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.

  1990cites this paper
• Production of interleukin-1 by bone marrow myeloma cells.

  1989cites this paper
• Suppression of the generation of lymphokine-activated killer (LAK) cells by serum-free supernatants of in vitro maintained tumour cell lines.

  1989cites this paper
• Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response

  1987cites this paper